Covenant Multifamily Offices’s Edwards Lifesciences EW Stock Holding History

Covenant Multifamily Offices’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$575K	Sell	5,280 -10	-0.2%	-$1.14K	0.1%	124
2021 Q2	$548K	Buy	5,290 +724	+16%	+$68.2K	0.1%	124
2021 Q1	$382K	Sell	4,566 -1,134	-20%	-$95.9K	0.08%	131
2020 Q4	$520K	Hold	5,700	–	–	0.09%	81
2020 Q3	$455K	Sell	5,700 -10,068	-64%	-$786K	0.09%	76
2020 Q2	$1.09M	Buy	15,768 +5,580	+55%	+$397K	0.21%	65
2020 Q1	$641K	Sell	10,188 -98,712	-91%	-$7.12M	0.16%	67
2019 Q4	$935K	Buy	108,900 +98,739	+972%	+$7.71M	0.16%	100
2019 Q3	$745K	Buy	10,161 +1,134	+13%	+$79.7K	0.16%	86
2019 Q2	$556K	Buy	+9,027	New	+$546K	0.12%	95

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Covenant Multifamily Offices's EW Position: Q3 2021 in Review

Covenant Multifamily Offices reduced its Edwards Lifesciences (EW) stake by 0.19% in Q3 2021, selling an estimated $1.14K and leaving 5,280 shares worth $575K. The position accounts for 0.1% of the portfolio, ranked #124.

Covenant Multifamily Offices first reported a position in EW in Q2 2019 and has held it in 10 quarters since. The position peaked at $1.09M in Q2 2020. 1,228 funds tracked by Wall St. Rank hold EW as of Q3 2021.

Covenant Multifamily Offices held 5,280 shares of Edwards Lifesciences worth $575K as of Q3 2021.
Covenant Multifamily Offices sold 10 Edwards Lifesciences shares in Q3 2021, an estimated $1.14K.
Edwards Lifesciences made up 0.1% of Covenant Multifamily Offices's portfolio in Q3 2021, its #124 holding.
Covenant Multifamily Offices first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 10 quarters since.
Covenant Multifamily Offices's Edwards Lifesciences position peaked at $1.09M in Q2 2020.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.